Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
Abroad (travel likely)RecruitingPHASE2
Conditions
C3 Glomerulopathy · Membranoproliferative Glomerulonephritis · Complement Abnormality · Dense Deposit Disease · C3 Glomerulonephritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sahlgrenska Hospital, Gothenburg, Sweden
Region Skåne Skåne Universitetssjukhus, Lund, Sweden
Karolinska Hospital, Stockholm, Sweden
Akademiska sjukhuset, Uppsala, Sweden
Study leads
Diana Karpman
Principal Investigator
Region Skane